“…Figure 2. Examples of potential use cases for kidney tubule injury and dysfunction biomarkers in clinical practice, for the purposes of prognosis, 20,27,37 treatment selection, 36 monitoring for treatment effectiveness, 41,42 monitoring for medication safety, 29,43 and distinguishing injury from hemodynamic causes of declining eGFR. [33][34][35] Abbreviations: CKD, chronic kidney disease; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; HIV, human immunodeficiency virus.…”